id	sid	tid	token	lemma	pos
work_m2qwbxu7vfekpnb34nmbb27oq4	1	1	hed_47_7-toc.tex	hed_47_7-toc.tex	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	2	Headache	Headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	3	ISSN	ISSN	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	4	0017	0017	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	1	5	-	-	HYPH
work_m2qwbxu7vfekpnb34nmbb27oq4	1	6	8748	8748	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	1	7	C	c	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	1	8	©	©	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	1	9	2007	2007	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	1	10	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	1	11	Author	author	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	1	12	doi	doi	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	1	13	:	:	:
work_m2qwbxu7vfekpnb34nmbb27oq4	1	14	10.1111	10.1111	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	1	15	/	/	SYM
work_m2qwbxu7vfekpnb34nmbb27oq4	1	16	j.1526	j.1526	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	17	-	-	HYPH
work_m2qwbxu7vfekpnb34nmbb27oq4	1	18	4610.2007.00875.x	4610.2007.00875.x	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	1	19	Journal	Journal	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	20	compilation	compilation	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	1	21	C	C	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	22	©	©	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	23	2007	2007	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	1	24	American	American	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	25	Headache	Headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	26	Society	Society	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	27	Published	publish	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	1	28	by	by	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	1	29	Blackwell	Blackwell	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	30	Publishing	Publishing	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	31	NIH	NIH	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	32	Funding	Funding	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	33	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	1	34	Research	Research	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	35	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	1	36	Headache	Headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	37	Disorders	Disorders	NNPS
work_m2qwbxu7vfekpnb34nmbb27oq4	1	38	:	:	:
work_m2qwbxu7vfekpnb34nmbb27oq4	1	39	Does	do	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	1	40	It	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	1	41	Matter	matter	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	1	42	?	?	.
work_m2qwbxu7vfekpnb34nmbb27oq4	2	1	Migraine	migraine	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	2	2	disorders	disorder	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	2	3	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	2	4	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	2	5	epilepsies	epilepsy	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	2	6	have	have	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	2	7	much	much	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	2	8	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	2	9	common	common	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	2	10	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	3	1	Both	both	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	3	2	are	be	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	3	3	highly	highly	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	3	4	prevalent	prevalent	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	3	5	paroxysmal	paroxysmal	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	3	6	neurological	neurological	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	3	7	disorders	disorder	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	3	8	that	that	WDT
work_m2qwbxu7vfekpnb34nmbb27oq4	3	9	have	have	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	3	10	peak	peak	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	3	11	incidence	incidence	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	3	12	prior	prior	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	3	13	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	3	14	adulthood	adulthood	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	3	15	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	3	16	may	may	MD
work_m2qwbxu7vfekpnb34nmbb27oq4	3	17	be	be	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	3	18	life	life	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	3	19	-	-	HYPH
work_m2qwbxu7vfekpnb34nmbb27oq4	3	20	long	long	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	3	21	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	4	1	They	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	4	2	are	be	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	4	3	also	also	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	4	4	often	often	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	4	5	co	co	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	4	6	-	-	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	4	7	morbid	morbid	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	4	8	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	5	1	Both	both	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	5	2	appear	appear	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	5	3	to	to	TO
work_m2qwbxu7vfekpnb34nmbb27oq4	5	4	share	share	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	5	5	important	important	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	5	6	pathogenic	pathogenic	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	5	7	mechanisms	mechanism	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	5	8	involving	involve	VBG
work_m2qwbxu7vfekpnb34nmbb27oq4	5	9	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	5	10	same	same	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	5	11	genes	gene	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	5	12	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	5	13	electro-	electro-	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	5	14	physiological	physiological	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	5	15	events	event	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	5	16	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	5	17	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	5	18	they	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	5	19	are	be	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	5	20	often	often	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	5	21	responsive	responsive	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	5	22	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	5	23	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	5	24	same	same	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	5	25	medications.1	medications.1	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	5	26	Both	both	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	5	27	are	be	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	5	28	associated	associate	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	5	29	with	with	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	5	30	huge	huge	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	5	31	economic	economic	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	5	32	costs	cost	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	5	33	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	5	34	profound	profound	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	5	35	disabilities	disability	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	5	36	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	6	1	While	while	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	2	pro-	pro-	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	3	longed	long	VBD
work_m2qwbxu7vfekpnb34nmbb27oq4	6	4	seizures	seizure	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	6	5	may	may	MD
work_m2qwbxu7vfekpnb34nmbb27oq4	6	6	be	be	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	6	7	fatal	fatal	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	6	8	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	6	9	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	6	10	far	far	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	6	11	higher	high	JJR
work_m2qwbxu7vfekpnb34nmbb27oq4	6	12	prevalence	prevalence	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	13	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	14	migraine	migraine	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	15	leads	lead	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	6	16	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	17	>	>	XX
work_m2qwbxu7vfekpnb34nmbb27oq4	6	18	85	85	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	6	19	%	%	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	20	more	more	RBR
work_m2qwbxu7vfekpnb34nmbb27oq4	6	21	lost	lost	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	6	22	years	year	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	6	23	annually	annually	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	6	24	from	from	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	25	death	death	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	26	or	or	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	6	27	disability	disability	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	28	than	than	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	29	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	6	30	epilepsies.2	epilepsies.2	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	6	31	Given	give	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	32	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	6	33	close	close	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	6	34	parallels	parallel	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	6	35	between	between	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	36	these	these	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	6	37	disor-	disor-	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	6	38	ders	der	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	6	39	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	6	40	why	why	WRB
work_m2qwbxu7vfekpnb34nmbb27oq4	6	41	then	then	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	6	42	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	6	43	over	over	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	44	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	6	45	past	past	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	6	46	15	15	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	6	47	years	year	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	6	48	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	6	49	have	have	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	6	50	10	10	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	6	51	new	new	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	6	52	medications	medication	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	6	53	been	be	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	54	FDA	FDA	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	6	55	-	-	HYPH
work_m2qwbxu7vfekpnb34nmbb27oq4	6	56	approved	approve	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	57	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	58	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	6	59	treatment	treatment	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	60	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	61	epilepsy	epilepsy	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	62	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	6	63	whereas	whereas	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	64	only	only	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	6	65	1	1	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	6	66	new	new	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	6	67	medication	medication	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	68	(	(	-LRB-
work_m2qwbxu7vfekpnb34nmbb27oq4	6	69	plus	plus	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	6	70	6	6	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	6	71	“	"	``
work_m2qwbxu7vfekpnb34nmbb27oq4	6	72	me-	me-	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	73	too	too	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	6	74	”	"	''
work_m2qwbxu7vfekpnb34nmbb27oq4	6	75	drugs	drug	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	6	76	)	)	-RRB-
work_m2qwbxu7vfekpnb34nmbb27oq4	6	77	has	have	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	6	78	been	be	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	79	approved	approve	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	80	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	81	migraine	migraine	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	82	(	(	-LRB-
work_m2qwbxu7vfekpnb34nmbb27oq4	6	83	Table	table	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	6	84	)	)	-RRB-
work_m2qwbxu7vfekpnb34nmbb27oq4	6	85	?	?	.
work_m2qwbxu7vfekpnb34nmbb27oq4	7	1	One	one	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	7	2	possibility	possibility	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	7	3	is	be	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	7	4	that	that	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	7	5	research	research	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	7	6	efforts	effort	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	7	7	have	have	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	7	8	been	be	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	7	9	sim-	sim-	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	7	10	ilarly	ilarly	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	7	11	aggressive	aggressive	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	7	12	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	7	13	both	both	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	7	14	groups	group	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	7	15	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	7	16	disorders	disorder	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	7	17	but	but	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	7	18	that	that	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	7	19	comparatively	comparatively	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	7	20	more	more	JJR
work_m2qwbxu7vfekpnb34nmbb27oq4	7	21	migraine	migraine	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	7	22	trials	trial	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	7	23	failed	fail	VBD
work_m2qwbxu7vfekpnb34nmbb27oq4	7	24	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	8	1	It	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	8	2	is	be	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	8	3	also	also	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	8	4	conceivable	conceivable	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	8	5	that	that	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	6	fewer	few	JJR
work_m2qwbxu7vfekpnb34nmbb27oq4	8	7	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	8	8	clinical	clinical	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	8	9	trials	trial	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	8	10	were	be	VBD
work_m2qwbxu7vfekpnb34nmbb27oq4	8	11	performed	perform	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	12	due	due	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	13	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	14	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	8	15	lack	lack	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	16	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	17	interest	interest	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	18	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	19	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	8	20	part	part	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	21	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	22	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	8	23	pharmaceutical	pharmaceutical	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	24	industry	industry	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	25	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	8	26	though	though	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	27	this	this	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	8	28	is	be	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	8	29	unlikely	unlikely	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	8	30	given	give	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	31	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	8	32	enormous	enormous	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	8	33	size	size	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	34	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	35	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	8	36	migraine	migraine	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	8	37	market	market	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	8	38	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	9	1	Regardless	regardless	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	9	2	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	9	3	these	these	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	9	4	possibilities	possibility	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	9	5	are	be	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	9	6	beyond	beyond	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	9	7	investigation	investigation	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	9	8	given	give	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	9	9	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	9	10	absence	absence	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	9	11	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	9	12	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	9	13	comprehensive	comprehensive	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	9	14	national	national	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	9	15	registry	registry	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	9	16	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	9	17	clin-	clin-	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	9	18	ical	ical	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	9	19	trials	trial	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	9	20	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	10	1	There	there	EX
work_m2qwbxu7vfekpnb34nmbb27oq4	10	2	is	be	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	10	3	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	10	4	however	however	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	10	5	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	10	6	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	10	7	much	much	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	10	8	more	more	RBR
work_m2qwbxu7vfekpnb34nmbb27oq4	10	9	plausible	plausible	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	10	10	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	10	11	simple	simple	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	10	12	explanation	explanation	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	10	13	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	10	14	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	10	15	discrepancy	discrepancy	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	10	16	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	10	17	drug	drug	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	10	18	ap-	ap-	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	10	19	provals	proval	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	10	20	:	:	:
work_m2qwbxu7vfekpnb34nmbb27oq4	10	21	there	there	EX
work_m2qwbxu7vfekpnb34nmbb27oq4	10	22	were	be	VBD
work_m2qwbxu7vfekpnb34nmbb27oq4	10	23	fewer	few	JJR
work_m2qwbxu7vfekpnb34nmbb27oq4	10	24	promising	promising	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	10	25	compounds	compound	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	10	26	avail-	avail-	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	10	27	able	able	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	10	28	to	to	TO
work_m2qwbxu7vfekpnb34nmbb27oq4	10	29	test	test	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	10	30	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	10	31	migraine	migraine	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	10	32	clinical	clinical	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	10	33	trials	trial	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	10	34	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	11	1	Why	why	WRB
work_m2qwbxu7vfekpnb34nmbb27oq4	11	2	might	may	MD
work_m2qwbxu7vfekpnb34nmbb27oq4	11	3	this	this	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	11	4	be	be	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	11	5	so	so	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	11	6	?	?	.
work_m2qwbxu7vfekpnb34nmbb27oq4	12	1	Abundant	abundant	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	12	2	evidence	evidence	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	3	shows	show	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	12	4	that	that	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	5	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	12	6	seminal	seminal	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	7	stud-	stud-	XX
work_m2qwbxu7vfekpnb34nmbb27oq4	12	8	ies	ie	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	12	9	that	that	WDT
work_m2qwbxu7vfekpnb34nmbb27oq4	12	10	lead	lead	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	12	11	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	12	innovative	innovative	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	12	13	pharmaceuticals	pharmaceutical	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	12	14	are	be	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	12	15	most	most	RBS
work_m2qwbxu7vfekpnb34nmbb27oq4	12	16	often	often	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	12	17	performed	perform	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	18	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	19	publicly	publicly	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	12	20	funded	fund	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	21	research	research	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	22	laborato-	laborato-	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	23	ries	rie	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	12	24	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	12	25	not	not	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	12	26	those	those	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	12	27	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	28	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	12	29	pharmaceutical	pharmaceutical	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	12	30	industry.3	industry.3	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	12	31	Federal	Federal	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	12	32	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	33	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	34	research	research	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	35	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	36	epilepsy	epilepsy	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	37	has	have	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	12	38	always	always	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	12	39	hugely	hugely	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	12	40	out-	out-	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	12	41	paced	pace	VBD
work_m2qwbxu7vfekpnb34nmbb27oq4	12	42	that	that	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	43	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	44	migraine	migraine	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	12	45	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	13	1	Over	over	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	2	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	13	3	past	past	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	13	4	several	several	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	13	5	years	year	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	13	6	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	13	7	mean	mean	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	13	8	annual	annual	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	13	9	NIH	NIH	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	13	10	expenditures	expenditure	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	13	11	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	12	epilepsy	epilepsy	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	13	have	have	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	13	14	been	be	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	15	∼$101M4	∼$101m4	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	13	16	compared	compare	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	17	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	18	∼$13M5	∼$13M5	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	13	19	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	20	migraine	migraine	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	21	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	13	22	with	with	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	23	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	13	24	comparable	comparable	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	13	25	disparity	disparity	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	26	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	27	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	28	every	every	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	13	29	year	year	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	30	since	since	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	31	1972	1972	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	13	32	—	—	:
work_m2qwbxu7vfekpnb34nmbb27oq4	13	33	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	13	34	earliest	early	JJS
work_m2qwbxu7vfekpnb34nmbb27oq4	13	35	year	year	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	36	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	37	available	available	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	13	38	records	record	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	13	39	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	40	NIH	NIH	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	13	41	grants	grant	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	13	42	(	(	-LRB-
work_m2qwbxu7vfekpnb34nmbb27oq4	13	43	Figure	figure	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	13	44	)	)	-RRB-
work_m2qwbxu7vfekpnb34nmbb27oq4	13	45	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	14	1	What	what	WP
work_m2qwbxu7vfekpnb34nmbb27oq4	14	2	did	do	VBD
work_m2qwbxu7vfekpnb34nmbb27oq4	14	3	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	14	4	federal	federal	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	14	5	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	14	6	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	14	7	epilepsy	epilepsy	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	14	8	pur-	pur-	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	14	9	chase	chase	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	14	10	?	?	.
work_m2qwbxu7vfekpnb34nmbb27oq4	15	1	Fundamental	fundamental	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	15	2	research	research	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	15	3	beginning	begin	VBG
work_m2qwbxu7vfekpnb34nmbb27oq4	15	4	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	15	5	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	15	6	1970s	1970	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	15	7	led	lead	VBD
work_m2qwbxu7vfekpnb34nmbb27oq4	15	8	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	15	9	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	15	10	development	development	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	15	11	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	15	12	epilepsy	epilepsy	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	15	13	animal	animal	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	15	14	models	model	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	15	15	that	that	WDT
work_m2qwbxu7vfekpnb34nmbb27oq4	15	16	enabled	enable	VBD
work_m2qwbxu7vfekpnb34nmbb27oq4	15	17	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	15	18	screening	screening	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	15	19	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	15	20	drugs	drug	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	15	21	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	15	22	anticonvul-	anticonvul-	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	15	23	sant	sant	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	15	24	properties	property	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	15	25	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	16	1	The	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	16	2	NIH	NIH	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	3	then	then	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	16	4	funded	fund	VBD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	5	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	16	6	provided	provide	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	7	oversight	oversight	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	8	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	9	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	16	10	program	program	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	11	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	12	accelerated	accelerate	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	13	screening	screening	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	14	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	15	Table	table	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	16	—	—	:
work_m2qwbxu7vfekpnb34nmbb27oq4	16	17	New	New	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	18	Molecular	Molecular	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	19	Entities	Entities	NNPS
work_m2qwbxu7vfekpnb34nmbb27oq4	16	20	Approved	approve	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	21	by	by	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	22	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	16	23	FDA	FDA	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	24	Since	since	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	25	1992	1992	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	26	by	by	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	27	Indication	Indication	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	28	Priority	Priority	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	29	Review	Review	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	30	Standard	Standard	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	31	Review	Review	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	32	Epilepsy	Epilepsy	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	33	Felbamate	Felbamate	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	34	1993	1993	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	35	Fosphenytoin	Fosphenytoin	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	36	1996	1996	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	37	Gabapentin	Gabapentin	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	38	1993	1993	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	39	Topiramate	Topiramate	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	40	1996	1996	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	41	Lamotrigine	lamotrigine	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	42	1994	1994	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	43	Tiagabine	Tiagabine	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	44	1997	1997	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	45	Pregabalin	Pregabalin	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	46	2004	2004	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	47	Levetiracetam	Levetiracetam	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	48	1999	1999	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	49	Oxcarbazepine	Oxcarbazepine	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	50	2000	2000	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	51	Zonisamide	Zonisamide	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	52	2000	2000	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	53	Migraine	Migraine	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	54	Sumatriptan	Sumatriptan	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	55	1992	1992	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	56	Zolmitriptan	Zolmitriptan	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	57	1997	1997	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	58	Naratriptan	Naratriptan	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	59	1998	1998	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	60	Rizatriptan	Rizatriptan	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	61	1998	1998	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	62	Almotriptan	Almotriptan	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	63	2001	2001	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	64	Frovatriptan	Frovatriptan	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	65	2001	2001	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	66	Eletriptan	Eletriptan	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	67	2002	2002	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	68	An	an	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	16	69	NME	NME	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	70	is	be	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	16	71	defined	define	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	72	as	as	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	73	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	16	74	drug	drug	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	75	that	that	WDT
work_m2qwbxu7vfekpnb34nmbb27oq4	16	76	contains	contain	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	16	77	no	no	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	16	78	active	active	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	16	79	moiety	moiety	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	80	that	that	WDT
work_m2qwbxu7vfekpnb34nmbb27oq4	16	81	has	have	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	16	82	been	be	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	83	approved	approve	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	84	by	by	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	85	FDA	FDA	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	86	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	87	any	any	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	16	88	other	other	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	16	89	application	application	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	90	submitted	submit	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	91	under	under	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	92	section	section	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	93	505(b	505(b	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	16	94	)	)	-RRB-
work_m2qwbxu7vfekpnb34nmbb27oq4	16	95	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	16	96	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	16	97	Federal	Federal	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	98	Food	Food	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	99	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	16	100	Drug	Drug	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	101	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	16	102	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	16	103	Cosmetic	Cosmetic	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	104	Act	Act	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	16	105	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	17	1	A	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	17	2	priority	priority	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	3	review	review	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	4	by	by	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	5	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	17	6	FDA	FDA	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	17	7	is	be	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	17	8	accorded	accord	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	9	drugs	drug	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	17	10	that	that	WDT
work_m2qwbxu7vfekpnb34nmbb27oq4	17	11	are	be	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	17	12	believed	believe	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	13	to	to	TO
work_m2qwbxu7vfekpnb34nmbb27oq4	17	14	represent	represent	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	17	15	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	17	16	significant	significant	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	17	17	improvement	improvement	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	18	compared	compare	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	19	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	20	marketed	market	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	21	products	product	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	17	22	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	17	23	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	24	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	17	25	treatment	treatment	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	26	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	17	27	diagnosis	diagnosis	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	28	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	17	29	or	or	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	17	30	prevention	prevention	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	31	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	32	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	17	33	disease	disease	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	17	34	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	18	1	A	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	18	2	standard	standard	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	18	3	review	review	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	18	4	by	by	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	18	5	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	18	6	FDA	FDA	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	18	7	is	be	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	18	8	accorded	accord	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	18	9	drugs	drug	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	18	10	that	that	WDT
work_m2qwbxu7vfekpnb34nmbb27oq4	18	11	appear	appear	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	18	12	to	to	TO
work_m2qwbxu7vfekpnb34nmbb27oq4	18	13	have	have	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	18	14	therapeutic	therapeutic	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	18	15	qualities	quality	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	18	16	similar	similar	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	18	17	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	18	18	those	those	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	18	19	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	18	20	1	1	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	18	21	or	or	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	18	22	more	more	RBR
work_m2qwbxu7vfekpnb34nmbb27oq4	18	23	already	already	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	18	24	marketed	market	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	18	25	drugs	drug	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	18	26	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	19	1	993	993	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	19	2	994	994	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	19	3	July	July	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	19	4	/	/	SYM
work_m2qwbxu7vfekpnb34nmbb27oq4	19	5	August	August	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	19	6	2007	2007	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	19	7	Figure	Figure	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	19	8	—	—	:
work_m2qwbxu7vfekpnb34nmbb27oq4	19	9	NIH	NIH	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	19	10	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	19	11	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	19	12	migraine	migraine	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	19	13	versus	versus	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	19	14	epilepsy	epilepsy	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	19	15	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	20	1	The	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	20	2	relative	relative	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	20	3	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	4	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	5	each	each	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	20	6	disorder	disorder	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	7	is	be	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	20	8	obtained	obtain	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	9	by	by	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	10	comparing	compare	VBG
work_m2qwbxu7vfekpnb34nmbb27oq4	20	11	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	20	12	number	number	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	13	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	14	documents	document	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	20	15	retrieved	retrieve	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	16	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	17	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	20	18	keywords	keyword	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	20	19	“	"	``
work_m2qwbxu7vfekpnb34nmbb27oq4	20	20	migraine	migraine	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	20	21	”	"	''
work_m2qwbxu7vfekpnb34nmbb27oq4	20	22	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	20	23	“	"	``
work_m2qwbxu7vfekpnb34nmbb27oq4	20	24	epilepsy	epilepsy	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	25	”	"	''
work_m2qwbxu7vfekpnb34nmbb27oq4	20	26	from	from	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	27	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	20	28	Computer	Computer	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	20	29	Retrieval	Retrieval	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	20	30	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	31	Information	Information	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	20	32	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	33	Scientific	Scientific	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	20	34	Projects	Projects	NNPS
work_m2qwbxu7vfekpnb34nmbb27oq4	20	35	(	(	-LRB-
work_m2qwbxu7vfekpnb34nmbb27oq4	20	36	CRISP)8	crisp)8	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	37	database	database	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	38	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	39	U.S.	U.S.	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	20	40	federally	federally	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	20	41	funded	fund	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	42	biomedical	biomedical	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	20	43	research	research	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	20	44	projects	project	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	20	45	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	21	1	CRISP	CRISP	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	21	2	includes	include	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	21	3	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	21	4	document	document	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	5	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	6	every	every	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	21	7	year	year	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	8	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	9	every	every	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	21	10	federally	federally	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	21	11	funded	funded	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	21	12	(	(	-LRB-
work_m2qwbxu7vfekpnb34nmbb27oq4	21	13	mostly	mostly	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	21	14	NIH	NIH	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	21	15	)	)	-RRB-
work_m2qwbxu7vfekpnb34nmbb27oq4	21	16	biomedical	biomedical	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	21	17	research	research	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	18	grant	grant	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	19	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	21	20	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	21	21	an	an	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	21	22	analysis	analysis	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	23	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	24	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	21	25	relative	relative	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	21	26	number	number	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	27	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	28	CRISP	CRISP	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	21	29	documents	document	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	21	30	provides	provide	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	21	31	an	an	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	21	32	approximation	approximation	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	33	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	34	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	21	35	relative	relative	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	21	36	weight	weight	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	37	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	38	U.S.	U.S.	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	21	39	federal	federal	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	21	40	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	41	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	42	each	each	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	21	43	disorder	disorder	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	21	44	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	22	1	compounds	compound	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	22	2	developed	develop	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	22	3	by	by	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	22	4	academia	academia	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	22	5	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	22	6	industry.6	industry.6	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	22	7	Thirty	thirty	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	22	8	years	year	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	22	9	later	later	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	22	10	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	22	11	patients	patient	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	22	12	with	with	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	22	13	epilepsy	epilepsy	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	22	14	have	have	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	22	15	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	22	16	con-	con-	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	22	17	siderably	siderably	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	22	18	wider	wider	RBR
work_m2qwbxu7vfekpnb34nmbb27oq4	22	19	set	set	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	22	20	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	22	21	therapeutic	therapeutic	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	22	22	options	option	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	22	23	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	23	1	Headache	Headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	23	2	medicine	medicine	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	23	3	is	be	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	23	4	also	also	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	23	5	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	23	6	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	23	7	threshold	threshold	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	23	8	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	23	9	new	new	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	23	10	insights	insight	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	23	11	into	into	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	23	12	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	23	13	pathogenesis	pathogenesis	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	23	14	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	23	15	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	23	16	primary	primary	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	23	17	headache	headache	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	23	18	disorders	disorder	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	23	19	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	24	1	Animal	animal	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	24	2	models	model	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	24	3	relevant	relevant	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	24	4	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	24	5	drug	drug	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	24	6	screening	screening	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	24	7	are	be	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	24	8	beginning	begin	VBG
work_m2qwbxu7vfekpnb34nmbb27oq4	24	9	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	24	10	appear.7	appear.7	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	24	11	What	what	WP
work_m2qwbxu7vfekpnb34nmbb27oq4	24	12	is	be	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	24	13	needed	need	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	24	14	now	now	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	24	15	is	be	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	24	16	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	24	17	commitment	commitment	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	24	18	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	24	19	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	24	20	medicine	medicine	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	24	21	from	from	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	24	22	federal	federal	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	24	23	agen-	agen-	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	24	24	cies	cie	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	24	25	similar	similar	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	24	26	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	24	27	that	that	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	24	28	which	which	WDT
work_m2qwbxu7vfekpnb34nmbb27oq4	24	29	has	have	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	24	30	been	be	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	24	31	appropriately	appropriately	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	24	32	ex-	ex-	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	24	33	tended	tend	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	24	34	to	to	TO
work_m2qwbxu7vfekpnb34nmbb27oq4	24	35	epilepsy	epilepsy	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	24	36	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	25	1	Headache	Headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	25	2	medicine	medicine	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	25	3	requires	require	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	25	4	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	25	5	deserves	deserve	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	25	6	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	25	7	7.5-fold	7.5-fold	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	25	8	increase	increase	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	25	9	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	25	10	NIH	NIH	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	25	11	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	25	12	to	to	TO
work_m2qwbxu7vfekpnb34nmbb27oq4	25	13	bring	bring	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	25	14	it	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	25	15	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	25	16	parity	parity	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	25	17	with	with	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	25	18	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	25	19	epilepsies	epilepsy	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	25	20	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	26	1	Such	such	PDT
work_m2qwbxu7vfekpnb34nmbb27oq4	26	2	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	26	3	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	26	4	boost	boost	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	26	5	would	would	MD
work_m2qwbxu7vfekpnb34nmbb27oq4	26	6	dramatically	dramatically	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	26	7	increase	increase	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	26	8	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	26	9	number	number	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	26	10	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	26	11	laborato-	laborato-	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	26	12	ries	rie	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	26	13	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	26	14	this	this	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	26	15	field	field	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	26	16	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	26	17	ensure	ensure	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	26	18	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	26	19	training	training	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	26	20	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	26	21	an	an	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	26	22	expanded	expand	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	26	23	generation	generation	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	26	24	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	26	25	dedicated	dedicated	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	26	26	clinician	clinician	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	26	27	-	-	HYPH
work_m2qwbxu7vfekpnb34nmbb27oq4	26	28	investigators	investigator	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	26	29	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	27	1	More-	more-	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	27	2	over	over	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	27	3	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	27	4	newly	newly	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	27	5	funded	fund	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	27	6	laboratories	laboratory	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	27	7	would	would	MD
work_m2qwbxu7vfekpnb34nmbb27oq4	27	8	be	be	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	27	9	welcomed	welcome	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	27	10	into	into	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	27	11	academic	academic	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	27	12	neurology	neurology	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	27	13	departments	department	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	27	14	where	where	WRB
work_m2qwbxu7vfekpnb34nmbb27oq4	27	15	they	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	27	16	would	would	MD
work_m2qwbxu7vfekpnb34nmbb27oq4	27	17	provide	provide	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	27	18	visibility	visibility	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	27	19	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	27	20	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	27	21	medicine	medicine	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	27	22	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	27	23	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	27	24	nidus	nidus	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	27	25	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	27	26	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	27	27	specialty	specialty	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	27	28	clinical	clinical	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	27	29	training	training	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	27	30	programs	program	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	27	31	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	28	1	Based	base	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	2	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	3	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	28	4	example	example	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	5	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	6	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	28	7	epilepsies	epilepsy	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	28	8	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	28	9	real	real	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	28	10	benefits	benefit	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	28	11	will	will	MD
work_m2qwbxu7vfekpnb34nmbb27oq4	28	12	likely	likely	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	28	13	be	be	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	28	14	felt	feel	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	15	by	by	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	16	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	28	17	patients	patient	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	28	18	over	over	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	19	time	time	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	20	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	21	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	28	22	form	form	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	23	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	24	improved	improved	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	28	25	access	access	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	26	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	27	specialty	specialty	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	28	care	care	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	29	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	28	30	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	28	31	development	development	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	32	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	28	33	novel	novel	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	28	34	effective	effective	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	28	35	therapies	therapy	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	28	36	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	29	1	No	no	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	29	2	one	one	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	29	3	should	should	MD
work_m2qwbxu7vfekpnb34nmbb27oq4	29	4	expect	expect	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	29	5	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	29	6	NIH	NIH	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	29	7	to	to	TO
work_m2qwbxu7vfekpnb34nmbb27oq4	29	8	spontaneously	spontaneously	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	29	9	increase	increase	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	29	10	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	29	11	research	research	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	29	12	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	29	13	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	29	14	>	>	XX
work_m2qwbxu7vfekpnb34nmbb27oq4	29	15	$	$	$
work_m2qwbxu7vfekpnb34nmbb27oq4	29	16	100	100	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	29	17	M	M	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	29	18	annu-	annu-	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	29	19	ally	ally	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	29	20	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	30	1	Any	any	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	30	2	such	such	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	30	3	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	30	4	increase	increase	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	30	5	will	will	MD
work_m2qwbxu7vfekpnb34nmbb27oq4	30	6	be	be	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	30	7	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	30	8	hard	hard	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	30	9	-	-	HYPH
work_m2qwbxu7vfekpnb34nmbb27oq4	30	10	won	win	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	30	11	consequence	consequence	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	30	12	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	30	13	vigorous	vigorous	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	30	14	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	30	15	persistent	persistent	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	30	16	advocacy	advocacy	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	30	17	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	30	18	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	30	19	part	part	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	30	20	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	30	21	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	30	22	community	community	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	30	23	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	30	24	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	30	25	medicine	medicine	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	30	26	spe-	spe-	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	30	27	cialists	cialist	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	30	28	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	30	29	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	30	30	disorder	disorder	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	30	31	patients	patient	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	30	32	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	31	1	As	as	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	31	2	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	31	3	part	part	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	31	4	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	31	5	this	this	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	31	6	process	process	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	31	7	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	31	8	we	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	31	9	are	be	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	31	10	developing	develop	VBG
work_m2qwbxu7vfekpnb34nmbb27oq4	31	11	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	31	12	program	program	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	31	13	to	to	TO
work_m2qwbxu7vfekpnb34nmbb27oq4	31	14	bring	bring	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	31	15	this	this	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	31	16	issue	issue	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	31	17	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	31	18	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	31	19	close	close	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	31	20	attention	attention	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	31	21	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	31	22	federal	federal	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	31	23	lawmakers	lawmaker	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	31	24	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	32	1	We	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	32	2	are	be	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	32	3	working	work	VBG
work_m2qwbxu7vfekpnb34nmbb27oq4	32	4	to	to	TO
work_m2qwbxu7vfekpnb34nmbb27oq4	32	5	mobilize	mobilize	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	32	6	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	32	7	patients	patient	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	32	8	to	to	TO
work_m2qwbxu7vfekpnb34nmbb27oq4	32	9	advo-	advo-	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	32	10	cate	cate	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	32	11	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	32	12	their	-PRON-	PRP$
work_m2qwbxu7vfekpnb34nmbb27oq4	32	13	interests	interest	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	32	14	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	33	1	Furthermore	furthermore	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	33	2	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	33	3	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	4	September	September	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	33	5	25	25	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	33	6	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	33	7	26	26	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	33	8	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	33	9	2007	2007	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	33	10	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	33	11	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	33	12	medicine	medicine	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	13	clinicians	clinician	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	33	14	from	from	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	15	across	across	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	16	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	33	17	country	country	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	18	will	will	MD
work_m2qwbxu7vfekpnb34nmbb27oq4	33	19	participate	participate	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	33	20	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	21	an	an	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	33	22	event	event	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	23	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	24	Washington	Washington	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	33	25	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	33	26	DC	DC	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	33	27	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	33	28	that	that	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	29	we	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	33	30	call	call	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	33	31	“	"	``
work_m2qwbxu7vfekpnb34nmbb27oq4	33	32	Headache	Headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	33	33	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	34	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	33	35	Hill	Hill	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	33	36	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	33	37	”	"	''
work_m2qwbxu7vfekpnb34nmbb27oq4	33	38	At	at	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	39	that	that	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	33	40	time	time	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	41	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	33	42	we	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	33	43	will	will	MD
work_m2qwbxu7vfekpnb34nmbb27oq4	33	44	meet	meet	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	33	45	with	with	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	46	our	-PRON-	PRP$
work_m2qwbxu7vfekpnb34nmbb27oq4	33	47	Senators	Senators	NNPS
work_m2qwbxu7vfekpnb34nmbb27oq4	33	48	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	33	49	Representatives	Representatives	NNPS
work_m2qwbxu7vfekpnb34nmbb27oq4	33	50	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	33	51	press	press	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	33	52	them	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	33	53	to	to	TO
work_m2qwbxu7vfekpnb34nmbb27oq4	33	54	take	take	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	33	55	Congressional	congressional	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	33	56	action	action	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	57	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	58	in-	in-	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	33	59	crease	crease	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	60	NIH	NIH	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	33	61	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	33	62	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	34	1	We	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	34	2	welcome	welcome	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	34	3	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	34	4	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	34	5	strongly	strongly	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	34	6	urge	urge	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	34	7	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	34	8	all	all	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	34	9	U.S.	U.S.	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	34	10	headache	headache	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	34	11	specialists	specialist	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	34	12	to	to	TO
work_m2qwbxu7vfekpnb34nmbb27oq4	34	13	join	join	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	34	14	us	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	34	15	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	35	1	The	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	35	2	success	success	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	35	3	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	35	4	this	this	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	35	5	initiative	initiative	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	35	6	depends	depend	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	35	7	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	35	8	large	large	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	35	9	numbers	number	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	35	10	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	35	11	participants	participant	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	35	12	coming	come	VBG
work_m2qwbxu7vfekpnb34nmbb27oq4	35	13	from	from	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	35	14	widespread	widespread	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	35	15	Congressional	congressional	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	35	16	districts	district	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	35	17	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	36	1	For	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	36	2	Headache	Headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	36	3	995	995	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	36	4	information	information	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	36	5	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	36	6	participation	participation	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	36	7	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	36	8	this	this	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	36	9	event	event	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	36	10	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	36	11	please	please	UH
work_m2qwbxu7vfekpnb34nmbb27oq4	36	12	email	email	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	36	13	me	-PRON-	PRP
work_m2qwbxu7vfekpnb34nmbb27oq4	36	14	at	at	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	36	15	robert.shapiro@uvm.edu	robert.shapiro@uvm.edu	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	36	16	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	37	1	The	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	37	2	lack	lack	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	37	3	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	37	4	NIH	NIH	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	37	5	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	37	6	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	37	7	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	37	8	research	research	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	37	9	is	be	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	37	10	an	an	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	37	11	injustice	injustice	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	37	12	that	that	WDT
work_m2qwbxu7vfekpnb34nmbb27oq4	37	13	receives	receive	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	37	14	no	no	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	37	15	media	medium	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	37	16	attention	attention	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	37	17	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	38	1	Its	-PRON-	PRP$
work_m2qwbxu7vfekpnb34nmbb27oq4	38	2	repercussions	repercussion	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	38	3	limit	limit	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	38	4	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	38	5	therapeutic	therapeutic	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	38	6	options	option	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	38	7	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	38	8	hope	hope	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	38	9	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	38	10	women	woman	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	38	11	who	who	WP
work_m2qwbxu7vfekpnb34nmbb27oq4	38	12	suffer	suffer	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	38	13	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	38	14	greater	great	JJR
work_m2qwbxu7vfekpnb34nmbb27oq4	38	15	numbers	number	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	38	16	from	from	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	38	17	mi-	mi-	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	38	18	graine	graine	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	38	19	or	or	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	38	20	chronic	chronic	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	38	21	daily	daily	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	38	22	headache	headache	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	38	23	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	38	24	as	as	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	38	25	well	well	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	38	26	as	as	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	38	27	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	38	28	men	man	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	38	29	who	who	WP
work_m2qwbxu7vfekpnb34nmbb27oq4	38	30	may	may	MD
work_m2qwbxu7vfekpnb34nmbb27oq4	38	31	preferentially	preferentially	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	38	32	suffer	suffer	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	38	33	from	from	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	38	34	cluster	cluster	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	38	35	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	38	36	or	or	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	38	37	posttraumatic	posttraumatic	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	38	38	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	38	39	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	39	1	The	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	39	2	NIH	NIH	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	39	3	is	be	VBZ
work_m2qwbxu7vfekpnb34nmbb27oq4	39	4	mandated	mandate	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	39	5	to	to	TO
work_m2qwbxu7vfekpnb34nmbb27oq4	39	6	improve	improve	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	39	7	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	39	8	health	health	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	39	9	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	39	10	welfare	welfare	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	39	11	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	39	12	all	all	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	39	13	Americans	Americans	NNPS
work_m2qwbxu7vfekpnb34nmbb27oq4	39	14	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	39	15	how-	how-	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	39	16	ever	ever	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	39	17	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	39	18	its	-PRON-	PRP$
work_m2qwbxu7vfekpnb34nmbb27oq4	39	19	expenditures	expenditure	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	39	20	do	do	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	39	21	not	not	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	39	22	reflect	reflect	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	39	23	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	39	24	societal	societal	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	39	25	dis-	dis-	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	39	26	tribution	tribution	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	39	27	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	39	28	disease	disease	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	39	29	-	-	HYPH
work_m2qwbxu7vfekpnb34nmbb27oq4	39	30	related	relate	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	39	31	economic	economic	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	39	32	costs	cost	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	39	33	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	39	34	dis-	dis-	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	39	35	abilities	ability	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	39	36	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	40	1	Disabled	disabled	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	40	2	headache	headache	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	40	3	patients	patient	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	40	4	have	have	VBP
work_m2qwbxu7vfekpnb34nmbb27oq4	40	5	been	be	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	40	6	de-	de-	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	40	7	nied	nie	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	40	8	equal	equal	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	40	9	access	access	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	40	10	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	40	11	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	40	12	benefits	benefit	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	40	13	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	40	14	publicly	publicly	RB
work_m2qwbxu7vfekpnb34nmbb27oq4	40	15	funded	fund	VBN
work_m2qwbxu7vfekpnb34nmbb27oq4	40	16	research	research	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	40	17	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	41	1	Redress	redress	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	41	2	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	41	3	this	this	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	41	4	inequity	inequity	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	41	5	should	should	MD
work_m2qwbxu7vfekpnb34nmbb27oq4	41	6	have	have	VB
work_m2qwbxu7vfekpnb34nmbb27oq4	41	7	a	a	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	41	8	trans-	trans-	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	41	9	formative	formative	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	41	10	beneficial	beneficial	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	41	11	effect	effect	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	41	12	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	41	13	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	41	14	practice	practice	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	41	15	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	41	16	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	41	17	medicine	medicine	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	41	18	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	42	1	Robert	Robert	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	2	E.	E.	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	3	Shapiro	Shapiro	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	4	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	42	5	MD	MD	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	6	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	42	7	PhD	PhD	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	8	Department	Department	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	9	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	42	10	Neurology	Neurology	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	11	University	University	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	12	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	42	13	Vermont	Vermont	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	14	College	College	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	15	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	42	16	Medicine	Medicine	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	17	Burlington	Burlington	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	18	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	42	19	VT	VT	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	20	REFERENCES	REFERENCES	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	42	21	1	1	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	42	22	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	43	1	Calabresi	Calabresi	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	43	2	P	P	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	43	3	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	43	4	Galletti	Galletti	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	43	5	F	F	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	43	6	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	43	7	Rossi	Rossi	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	43	8	C	C	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	43	9	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	43	10	et	et	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	43	11	al	al	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	43	12	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	44	1	Antiepilep-	Antiepilep-	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	44	2	tic	tic	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	44	3	drugs	drug	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	44	4	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	44	5	migraine	migraine	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	44	6	:	:	:
work_m2qwbxu7vfekpnb34nmbb27oq4	44	7	From	from	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	44	8	clinical	clinical	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	44	9	aspects	aspect	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	44	10	to	to	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	44	11	cellular	cellular	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	44	12	mechanisms	mechanism	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	44	13	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	45	1	Trends	Trends	NNPS
work_m2qwbxu7vfekpnb34nmbb27oq4	45	2	Pharmacol	Pharmacol	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	45	3	Sci	Sci	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	45	4	..	..	NFP
work_m2qwbxu7vfekpnb34nmbb27oq4	45	5	2007	2007	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	45	6	;	;	:
work_m2qwbxu7vfekpnb34nmbb27oq4	45	7	28:188	28:188	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	45	8	-	-	SYM
work_m2qwbxu7vfekpnb34nmbb27oq4	45	9	195	195	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	45	10	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	46	1	2	2	LS
work_m2qwbxu7vfekpnb34nmbb27oq4	46	2	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	47	1	Murray	Murray	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	47	2	CJL	CJL	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	47	3	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	47	4	Lopez	Lopez	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	47	5	AD	AD	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	47	6	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	47	7	Mathers	Mathers	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	47	8	CD	CD	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	47	9	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	47	10	Stein	Stein	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	47	11	C.	C.	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	47	12	The	The	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	47	13	global	global	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	47	14	burden	burden	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	47	15	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	47	16	disease	disease	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	47	17	2000	2000	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	47	18	project	project	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	47	19	:	:	:
work_m2qwbxu7vfekpnb34nmbb27oq4	47	20	Aims	aim	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	47	21	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	47	22	methods	method	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	47	23	and	and	CC
work_m2qwbxu7vfekpnb34nmbb27oq4	47	24	data	datum	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	47	25	sources	source	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	47	26	2001	2001	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	47	27	National	National	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	47	28	Institute	Institute	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	47	29	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	47	30	Aging	age	VBG
work_m2qwbxu7vfekpnb34nmbb27oq4	47	31	Grant	Grant	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	47	32	1-P01-AG17625	1-p01-ag17625	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	47	33	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	48	1	3	3	LS
work_m2qwbxu7vfekpnb34nmbb27oq4	48	2	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	49	1	Zinner	Zinner	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	49	2	DE	DE	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	49	3	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	50	1	Medical	medical	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	50	2	R&D	r&d	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	50	3	at	at	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	50	4	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	50	5	turn	turn	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	50	6	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	50	7	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	50	8	millen-	millen-	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	50	9	nium	nium	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	50	10	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	51	1	Health	Health	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	51	2	Affairs	Affairs	NNPS
work_m2qwbxu7vfekpnb34nmbb27oq4	51	3	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	51	4	September	September	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	51	5	–	–	:
work_m2qwbxu7vfekpnb34nmbb27oq4	51	6	October	October	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	51	7	2001	2001	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	51	8	;	;	:
work_m2qwbxu7vfekpnb34nmbb27oq4	51	9	202	202	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	51	10	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	52	1	4	4	LS
work_m2qwbxu7vfekpnb34nmbb27oq4	52	2	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	53	1	NIH	NIH	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	53	2	estimates	estimate	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	53	3	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	53	4	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	53	5	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	53	6	various	various	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	53	7	diseases	disease	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	53	8	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	53	9	con-	con-	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	53	10	ditions	dition	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	53	11	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	53	12	research	research	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	53	13	areas	area	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	53	14	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	54	1	Available	available	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	54	2	at	at	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	54	3	:	:	:
work_m2qwbxu7vfekpnb34nmbb27oq4	54	4	http://www	http://www	ADD
work_m2qwbxu7vfekpnb34nmbb27oq4	54	5	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	55	1	nih.gov/news/fundingresearchareas.htm	nih.gov/news/fundingresearchareas.htm	ADD
work_m2qwbxu7vfekpnb34nmbb27oq4	55	2	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	56	1	5	5	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	56	2	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	57	1	Shapiro	Shapiro	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	57	2	RE	RE	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	57	3	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	57	4	Goadsby	Goadsby	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	57	5	PJ	PJ	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	57	6	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	58	1	The	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	58	2	long	long	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	58	3	drought	drought	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	58	4	:	:	:
work_m2qwbxu7vfekpnb34nmbb27oq4	58	5	The	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	58	6	dearth	dearth	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	58	7	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	58	8	public	public	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	58	9	funding	funding	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	58	10	for	for	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	58	11	headache	headache	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	58	12	research	research	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	58	13	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	59	1	Cephalalgia	cephalalgia	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	59	2	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	60	1	2007	2007	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	60	2	(	(	-LRB-
work_m2qwbxu7vfekpnb34nmbb27oq4	60	3	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	60	4	press	press	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	60	5	)	)	-RRB-
work_m2qwbxu7vfekpnb34nmbb27oq4	60	6	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	61	1	6	6	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	61	2	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	62	1	Porter	Porter	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	62	2	RJ	RJ	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	62	3	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	62	4	Hessie	Hessie	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	62	5	BJ	BJ	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	62	6	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	62	7	Cereghino	Cereghino	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	62	8	JJ	JJ	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	62	9	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	62	10	et	et	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	62	11	al	al	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	62	12	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	63	1	Advances	advance	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	63	2	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	63	3	the	the	DT
work_m2qwbxu7vfekpnb34nmbb27oq4	63	4	clinical	clinical	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	63	5	development	development	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	63	6	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	63	7	antiepileptic	antiepileptic	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	63	8	drugs	drug	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	63	9	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	64	1	Fed	Fed	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	64	2	Proc	Proc	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	64	3	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	65	1	1985	1985	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	65	2	;	;	:
work_m2qwbxu7vfekpnb34nmbb27oq4	65	3	44:2645	44:2645	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	65	4	-	-	SYM
work_m2qwbxu7vfekpnb34nmbb27oq4	65	5	2949	2949	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	65	6	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	66	1	7	7	LS
work_m2qwbxu7vfekpnb34nmbb27oq4	66	2	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	67	1	Ayata	Ayata	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	67	2	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	67	3	C	C	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	67	4	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	67	5	Jin	Jin	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	67	6	H	H	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	67	7	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	67	8	Kudo	Kudo	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	67	9	C	C	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	67	10	,	,	,
work_m2qwbxu7vfekpnb34nmbb27oq4	67	11	et	et	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	67	12	al	al	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	67	13	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	68	1	Suppression	suppression	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	68	2	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	68	3	cortical	cortical	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	68	4	spreading	spread	VBG
work_m2qwbxu7vfekpnb34nmbb27oq4	68	5	depression	depression	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	68	6	in	in	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	68	7	migraine	migraine	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	68	8	prophylaxis	prophylaxis	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	68	9	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	69	1	Ann	Ann	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	69	2	Neurol	Neurol	NNP
work_m2qwbxu7vfekpnb34nmbb27oq4	69	3	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	70	1	2006	2006	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	70	2	;	;	:
work_m2qwbxu7vfekpnb34nmbb27oq4	70	3	59:652	59:652	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	70	4	-	-	SYM
work_m2qwbxu7vfekpnb34nmbb27oq4	70	5	661	661	CD
work_m2qwbxu7vfekpnb34nmbb27oq4	70	6	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	71	1	8	8	LS
work_m2qwbxu7vfekpnb34nmbb27oq4	71	2	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	72	1	Computer	computer	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	72	2	retrieval	retrieval	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	72	3	of	of	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	72	4	information	information	NN
work_m2qwbxu7vfekpnb34nmbb27oq4	72	5	on	on	IN
work_m2qwbxu7vfekpnb34nmbb27oq4	72	6	scientific	scientific	JJ
work_m2qwbxu7vfekpnb34nmbb27oq4	72	7	projects	project	NNS
work_m2qwbxu7vfekpnb34nmbb27oq4	72	8	.	.	.
work_m2qwbxu7vfekpnb34nmbb27oq4	73	1	http://crisp.cit.nih.gov/.	http://crisp.cit.nih.gov/.	FW